Chemoinformaics analysis of Quindoline Antimicrobial
Molecular Weight | 218.259 | nRot | 0 |
Heavy Atom Molecular Weight | 208.179 | nRig | 20 |
Exact Molecular Weight | 218.084 | nRing | 4 |
Solubility: LogS | -4.773 | nHRing | 2 |
Solubility: LogP | 3.812 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 17 |
No. of Oxygen atom | 0 | No. of Arom Bond | 20 |
nHA | 1 | APOL | 33.9179 |
nHD | 1 | BPOL | 11.7421 |
QED | 0.477 |
Synth | 1.854 |
Natural Product Likeliness | -0.241 |
NR-PPAR-gamma | 0.954 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.051 |
Pgp-sub | 0.056 |
HIA | 0.006 |
CACO-2 | -4.969 |
MDCK | 0.0000162 |
BBB | 0.755 |
PPB | 0.973771 |
VDSS | 1.154 |
FU | 0.0150596 |
CYP1A2-inh | 0.995 |
CYP1A2-sub | 0.404 |
CYP2c19-inh | 0.608 |
CYP2c19-sub | 0.114 |
CYP2c9-inh | 0.487 |
CYP2c9-sub | 0.85 |
CYP2d6-inh | 0.761 |
CYP2d6-sub | 0.888 |
CYP3a4-inh | 0.558 |
CYP3a4-sub | 0.195 |
CL | 3.885 |
T12 | 0.331 |
hERG | 0.068 |
Ames | 0.875 |
ROA | 0.181 |
SkinSen | 0.918 |
Carcinogencity | 0.815 |
EI | 0.986 |
Respiratory | 0.927 |
NR-Aromatase | 0.743 |
Antiviral | No |
Prediction | 0.602631 |